잠시만 기다려 주세요. 로딩중입니다.

Impact of Mesenchymal Stem Cell Senescence on Inflammaging

BMB Reports 2020년 53권 2호 p.65 ~ 73
 ( Lee Byung-Chul ) - National Institutes of Health National Heart, Lung and Blood Institute

 ( Yu Kyung-Rok ) - Catholic University College of Medicine Department of Biomedicine and Health Sciences

Abstract


Life expectancy has dramatically increased around the world over the last few decades, and staying healthier longer, without chronic disease, has become an important issue. Although understanding aging is a grand challenge, our understanding of the mechanisms underlying the degeneration of cell and tissue functions with age and its contribution to chronic disease has greatly advanced during the past decade. As our immune system alters with aging, abnormal activation of immune cells leads to imbalance of innate and adaptive immunity and develops a persistent and mild systemic inflammation, inflammaging. With their unique therapeutic properties, such as immunomodulation and tissue regeneration, mesenchymal stem cells (MSCs) have been considered to be a promising source for treating autoimmune disease or as anti-aging therapy. Although direct evidence of the role of MSCs in inflammaging has not been thoroughly studied, features reported in senescent MSCs or the aging process of MSCs are associated with inflammaging; MSC niche-driven skewing of hematopoiesis toward the myeloid lineage or oncogenesis, production of pro-inflammatory cytokines, and weakening their modulative property on macrophage polarization, which plays a central role on inflammaging development. This review explores the role of senescent MSCs as an important regulator for onset and progression of inflammaging and as an effective target for anti-aging strategies.

키워드

Immunosenescence; Inflammaging; Mesenchymal stem cells; MSC niche; Senescence-associated secretory phenotype (SASP)
원문 및 링크아웃 정보
 
등재저널 정보